Separately, Stephens restated an “equal weight” rating and set a $13.00 price objective on shares of Veradigm in a report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $19.36.
Veradigm Stock Performance
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Cerity Partners LLC purchased a new position in Veradigm in the first quarter worth $804,000. Pinebridge Investments L.P. purchased a new position in Veradigm in the second quarter worth $26,000. Gladius Capital Management LP purchased a new position in Veradigm in the first quarter worth $28,000. Quadrant Capital Group LLC boosted its position in Veradigm by 200.5% in the second quarter. Quadrant Capital Group LLC now owns 2,263 shares of the software maker’s stock worth $29,000 after purchasing an additional 1,510 shares during the last quarter. Finally, Quarry LP purchased a new position in Veradigm in the first quarter worth $37,000.
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
- Five stocks we like better than Veradigm
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- These 5 small-cap impact stocks are making social change
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Alphabet slays its earnings but falls on its sword with cloud
- What Are Dividends? Buy the Best Dividend Stocks
- There’s nothing artificial about NVIDIA’s relationship with AI
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.